Axogen, Inc. — Director's Dealing 2017

Jul 18, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AxoGen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2017-07-17

Reporting Person: Gingrich Jon S. (Chief Commercial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-07-17	Employee Stock Option (right to purchase)	$16.85	A	115000	Acquired	2027-07-17	Common Stock (115000)	Direct

Footnotes

F1: All shares of Common Stock underlying the employee stock option will be fully vested on July 17, 2021 (4 years from the option grant date) based upon a vesting schedule whereby 25% of the aggregate shares vest on July 17, 2018 (12 months from the option grant date) and an additional 12.5% of the aggregate shares vest each 6 months thereafter.